Name | 1-(5-bromo-1,2,3,4-tetrahydroquinoxalin-6-yl)-2-(4,5-dihydro-1H-imidazol-2-yl)hydrazine |
---|---|
Synonyms |
6-Quinoxalinamine,5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-1,2,3,4-tetrahydro
5-bromo-6-(2-imidazolin-2-ylamino)-1,2,3,4-tetrahydroquinoxaline |
Density | 1.84g/cm3 |
---|---|
Boiling Point | 420ºC at 760 mmHg |
Molecular Formula | C11H15BrN6 |
Molecular Weight | 311.18100 |
Flash Point | 207.8ºC |
Exact Mass | 310.05400 |
PSA | 72.51000 |
LogP | 1.66650 |
Vapour Pressure | 2.92E-07mmHg at 25°C |
Index of Refraction | 1.798 |
~85% 134892-42-5 |
Literature: Allergan, Inc. Patent: US5077292 A1, 1991 ; |
Precursor 2 | |
---|---|
DownStream 0 |